RoundTable Healthcare Partners Announces Sale of Renaissance Lakewood, LLC
Renaissance is a premier contract development and manufacturing organization ("CDMO") focused on nasal and injectable pharmaceutical products, including unit-dose, bi-dose, and multi-dose nasal sprays as well as small-volume parenteral fill-finish vials. Renaissance was founded by RoundTable through the acquisition of two leading CDMOs, Confab Laboratories in 2010 and DPT Laboratories in 2012. Following the 2016 divestiture of its topicals division to Mylan N.V., the company has focused on advancing its intranasal and injectable dosage platforms. Through significant investments in leadership and talent, research & development, and state-of-the-art infrastructure, Renaissance has evolved into a leading, fully integrated CDMO and serves as a partner to both established and emerging pharmaceutical and biotech customers.
This transaction is expected to close in
Sidley Austin LLP acted as exclusive legal advisor to Renaissance and RoundTable in this transaction.
About RoundTable Healthcare Partners
RoundTable Healthcare Partners, based in
View original content:https://www.prnewswire.com/news-releases/roundtable-healthcare-partners-announces-sale-of-renaissance-lakewood-llc-302582062.html
SOURCE RoundTable Healthcare Partners
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yili Shares China's Whole-Value-Chain Dairy Symbiosis Model at FAO Global Conference
- Ethereum Price Prediction: ARK Puts $1.3 Billion on Chain as ETH Tests $2,800 and Pepeto Crosses $11.1 million
- Bitcoin Price Prediction: BTC Remains Below Its 2025 High as Remittix Unveils Its Upgraded PayFi Dashboard
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share